<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01154374</url>
  </required_header>
  <id_info>
    <org_study_id>MEBO-DFU-PILOTII-001</org_study_id>
    <nct_id>NCT01154374</nct_id>
  </id_info>
  <brief_title>A Clinical Study of the Safety and Efficacy of MEBO® Wound Ointment in Subjects With Diabetic Foot Ulcers (Pilot)</brief_title>
  <official_title>A Phase II, Randomized, Controlled, Two-Center Pilot Study of the Safety and Efficacy of Topically Applied MEBO® Wound Ointment Compared to Standard of Care in Subjects With Diabetic Foot Ulcers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Skingenix, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Skingenix, Inc.</source>
  <brief_summary>
    <textblock>
      The objective of this study is to evaluate the safety and efficacy of MEBO in the treatment
      of subjects with diabetic foot ulcers (DFUs).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a phase II, randomized, controlled, two-center pilot study designed to assess the
      safety and efficacy of MEBO in the treatment of subjects with DFUs. Subjects meeting entry
      criteria will be randomly assigned in a 1:1 ratio for up to 8 weeks of treatment with either
      MEBO or SOC.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of complete healing of the target ulcer.</measure>
    <time_frame>8 weeks of treatment period</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time required to achieve complete healing (days).</measure>
    <time_frame>8 weeks treatment period</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Absolute and percentage change in ulcer surface area from baseline to endpoint.</measure>
    <time_frame>8 weeks treatment period</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">7</enrollment>
  <condition>Diabetic Foot Ulcers</condition>
  <arm_group>
    <arm_group_label>MEBO Wound Ointment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Topical application twice daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard of Care (sterile saline moistened gauze)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical application twice daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MEBO Wound Ointment</intervention_name>
    <description>Topical application twice daily</description>
    <arm_group_label>MEBO Wound Ointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard of Care (sterile saline moistened gauze)</intervention_name>
    <arm_group_label>Standard of Care (sterile saline moistened gauze)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female ≥18 years of age

          -  Able and willing to provide informed consent

          -  Able and willing to comply with protocol visits and procedures

          -  Target ulcer duration of ≥4 weeks

        Exclusion Criteria:

          -  Ulcer of a non-diabetic pathophysiology

          -  Known or suspected allergies to any of the components of MEBO

          -  Malignancy on target ulcer foot

          -  Non-compliance in the screening or run-in period
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert S Kirsner, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Blume Podiatry Group, P.C.</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06515</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston University School of Medicine</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2010</study_first_submitted>
  <study_first_submitted_qc>June 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 30, 2010</study_first_posted>
  <disposition_first_submitted>July 19, 2013</disposition_first_submitted>
  <disposition_first_submitted_qc>July 19, 2013</disposition_first_submitted_qc>
  <disposition_first_posted type="Estimate">July 23, 2013</disposition_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetic Foot Ulcers (DFUs)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

